Nevro Corp. buy Royal Bank of Canada
Start price
01.12.23
/
50%
€17.20
Target price
01.12.24
€21.13
Performance (%)
-75.12%
End price
02.12.24
€4.28
Summary
This prediction ended on 02.12.24 with a price of €4.28. Massive losses of -75.12% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Nevro Corp. | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Nevro Corp. diskutieren
Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
Ratings data for NVRO provided by MarketBeat
In the thread Trading Nevro Corp.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten